Revisiting Post-Prostatectomy Salvage Radiation in the Age of Precision Oncology
This activity covers updates and evolving data in treating biochemically recurrent prostate cancer post-prostatectomy. One speaker covers fractionation: can we safely hypofractionate in the post-operative setting, or is the data more supportive of conventional fractionation?
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation
Unfavorable intermediate-risk prostate cancer is commonly encountered in clinical practice but there is relatively little data focusing on treatment outcomes specific and limited to this patient cohort, with most clinical trials grouping these patients with favorable intermediate-risk disease or
Category
  • SBRT
  • Brachytherapy
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Management of Small Cell Neuroendocrine Tumors of the Genitourinary Tract
Molecular diagnostics are rapidly evolving, leading to increased identification of previously 'rare' clinical entities.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Implementation of a Prostate SBRT Program in the Community Setting
Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups.
Category
  • SBRT
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
“Let’s Talk About It!” - Biology and Management of Sexual Toxicity Resulting from Prostate Cancer Radiotherapy
Radiation therapy-induced erectile dysfunction (RI-ED) occurs in over 50% of men treated for prostate cancer. The etiologies are likely multifactorial, consisting of a neurological, vascular and endocrine component.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Sexuality After Cancer Therapy
Patient fertility and sexual complications have few data available from clinical trials. It is noteworthy that the subject is infrequently discussed in institutional peer reviews/ M&M unless there is a Risk Management overlay.
Category
  • Gynecologic
  • Breast
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline
This activity provides practitioners with the knowledge to recognize optimal RT management decisions for anal cancer.
Category
  • Guidelines
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Oligometastatic Prostate Cancer: A Multidisciplinary Approach to Patient Care
This activity is a case-based discussion with a panel of experts in the field of GU malignancies discussing how to personalize treatment recommendations based on imaging (including MRI, Fluciclovine F18 and Ga68-PSMA scans), pathology and clinical findings for patients with oligometastatic diseas
Category
  • Genitourinary
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ROBIN Oligometastasis (OligoMET) Center: Using Biomarker Correlates from a Prostate Cancer Clinical Trial to Improve Future Outcomes
Metastasis is the final common lethal pathway for most cancer patient's demise and once cancer has metastasized, it was generally considered incurable.
Category
  • Genitourinary
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Renal SABR: Implementation of A New Standard of Care
This paper, using a question and answer format, comprehensively explores and presents the data for SABR treatment of patient’s with RCC. The data and clinical care aspects of patient selection, radiotherapy treatment planning and delivery and post-treatment follow-up care are presented.
Category
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00

Pages